EICHORCondition: Lymphoma, Non-Hodgkin's · Lymphoma, Diffuse Large B-Cell · Follicular Lymphoma · Sponsor: Eli Lilly and Company
The main purpose of this study is to evaluate safety and efficacy, and measure how much LY4584180 gets into the bloodstream and how long it takes the body to eliminate it in patients with previously treated blood cancers. For each participant, the study could last about 9 months or possibly longer including screening.
This description comes directly from the study's public registry record.
Trial question or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic - Scottsdale | Scottsdale, Arizona, United States | Recruiting |
| City of Hope | Duarte, California, United States | Recruiting |
| University of California, Los Angeles (UCLA) - Medical Center | Los Angeles, California, United States | Not Yet Recruiting |
| University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center | San Francisco, California, United States | Not Yet Recruiting |
| Colorado Blood Cancer Institute | Denver, Colorado, United States | Recruiting |
| University of Miami - Sylvester Cancer Center | Miami, Florida, United States | Recruiting |
| Florida Cancer Specialists - Sarasota | Sarasota, Florida, United States | Recruiting |
| Emory University Hospital | Atlanta, Georgia, United States | Recruiting |
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| Mayo Clinic - Rochester | Rochester, Minnesota, United States | Recruiting |
| Columbia University | New York, New York, United States | Recruiting |
+ 34 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07226843